A novel inhibitor of N6-methyladenosine demethylase FTO induces mRNA methylation and shows anti-canc

来源 :药学学报(英文版) | 被引量 : 0次 | 上传用户:wwwdps1
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
N6-methyladenosine(m6A)modification is critical for mRNA splicing,nuclear export,stabil-ity and translation.Fat mass and obesity-associated protein(FTO),the first identified m6A demethylase,is critical for cancer progression.Herein,we developed small-molecule inhibitors of FTO by virtual screening,structural optimization,and bioassay.As a result,two FTO inhibitors namely 18077 and 18097 were identified,which can selectively inhibit demethylase activity of FTO.Specifically,18097 bound to the active site of FTO and then inhibited cell cycle process and migration of cancer cells.In addition,18097 reprogrammed the epi-transcriptome of breast cancer cells,particularly for genes related to P53 pathway.18097 increased the abundance of m6A modification of suppressor of cytokine signaling 1(SOCS1)mRNA,which recruited IGF2BP1 to increase mRNA stability of SOCS1 and subsequently activated the P53 signaling pathway.Further,18097 suppressed cellular lipogenesis via downregulation of peroxisome proliferator-activated receptor gamma(PPARγ),CCAAT/enhancer-binding protein alpha(C/EBP α),and C/EBPβ.Animal studies confirmed that 18097 can significantly suppress in vivo growth and lung colonization of breast cancer cells.Collectively,we identified that FTO can work as a potential drug target and the small-molecule inhibitor 18097 can serve as a potential agent against breast cancer.
其他文献
Nonalcoholic fatty liver disease(NAFLD)has become one of the most prominent causes of chronic liver diseases and malignancies.However,few therapy has been approved.Radix Bupleuri(RB)is the most frequently used herbal medicine for the treatment of liver di
Parkin,an E3 ubiquitin ligase,plays a role in maintaining mitochondrial homeostasis through targeting damaged mitochondria for mitophagy.Accumulating evidence suggests that the acetylation modification of the key mitophagy machinery influences mitophagy l
Given the opposing effects of Akt and AMP-activated protein kinase(AMPK)on metabolic homeostasis,this study examined the effects of deletion of Akt2 and AMPKα2 on fat diet-induced hepatic steatosis.Akt2-Ampkα2 double knockout(DKO)mice were placed on high
A significant proportion of non-small cell lung cancer(NSCLC)patients experience accumu-lating chemotherapy-related adverse events,motivating the design of chemosensitizating strategies.The main cytotoxic damage induced by chemotherapeutic agents is DNA d
Genetic gain-of-function mutations of warm temperature-sensitive transient receptor poten-tial vanilloid 3(TRPV3)channel cause Olmsted syndrome characterized by severe itching and keratoder-ma,indicating that pharmacological inhibition of TRPV3 may hold p
Occupational and environmental exposures to industrial chemicals are well known to cause hepatotoxicity and liver injury.However,despite extensive evidence showing that exposure can lead to disease,current research approaches and regulatory policies fail
PEGylated-L-asparaginase(PEG-ASNase)is a chemotherapeutic agent used to treat pediatric acute lymphoblastic leukemia(ALL).Its use is avoided in adults due to its high risk of liver injury including hepatic steatosis,with obesity and older age considered r
2022年初,纳米材料领域的著名科学家、中国科学院外籍院士王中林,拓展了举世闻名的麦克斯韦方程组,相关论文发表在著名的材料学期刊《今日材料》(Materials Today)上.中国科学院北京纳米能源与系统研究所召开重大原创科学成果发布会,向多家媒体发布了这项研究成果.
期刊
With the understanding of microRNA(miRNA or miR)functions in tumor initiation,pro-gression,and metastasis,efforts are underway to develop new miRNA-based therapies.Very recently,we demonstrated effectiveness of a novel humanized bioengineered miR-124-3p p
Acetaminophen(APAP)overdose can induce liver injury and is the most frequent cause of acute liver failure in the United States.We investigated the role of p62/SQSTM1(referred to as p62)in APAP-induced liver injury(AILI)in mice.We found that the hepatic pr